Clinical Trials Update:&nbsp;Oct. 19, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
755619
Six Apart and LiveJournal combine to boast 6.5 million users and a growing business. Also: Microsoft unveils antivirus software.... Canada may stop internet drug sales to America.... and more.
767081
Â· Lancet fast-tracks research sponsored by drug firm Â· Health advisers consider vaccinating older women
266395
New publications, experiments and breakthroughs in biotechnology--and what they mean.
370141
FRIDAY, Jan. 11 (HealthDay News) -- Therapeutic vaccines to fight ovarian and breast cancer are in the first stage of clinical trials to determine their safety and effectiveness, researchers report.
703885
roundup Plus: WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations...Data center firms settle cookie suit.
730173
TORONTO - Some of the world&#39;s most prestigious medical journals have banded together to force pharmaceutical and medical device companies to report the full results of clinical trials, both positive and negative.
315060
roundup Plus: IronPort spam shield gets steelier...Via brings PCI Express to AMD PCs...Rice lab makes nano parts less toxic.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
596475
roundup Plus: Via brings PCI Express to AMD PCs...Rice lab makes nano parts less toxic...TV chip company gets $19 million.
93775
Encouraging phase II results of a trial to test the efficacy of a malaria vaccine for young children is published in this week&#39;s issue of THE LANCET (pp 1380, 1411).
535175
BioSante releases more info on the pivotal studies for its lead drug.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
438501
Here's what a newly approved drug looks like.